151 related articles for article (PubMed ID: 32769566)
1. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
[TBL] [Abstract][Full Text] [Related]
2. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations.
Suryaprakash S; George A; Langenburg S; Savaşan S
Ann Hematol; 2020 Dec; 99(12):2965-2967. PubMed ID: 32944792
[No Abstract] [Full Text] [Related]
3. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
[TBL] [Abstract][Full Text] [Related]
5. Generalized pure cutaneous Rosai-Dorfman disease: a link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?
Zheng M; Bi R; Li W; Landeck L; Chen JQ; Lao LM; Cai SQ; Yao YG; Man XY
Discov Med; 2013 Nov; 16(89):193-200. PubMed ID: 24229736
[TBL] [Abstract][Full Text] [Related]
6. Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease.
Lara-Reyna S; Poulter JA; Vasconcelos EJR; Kacar M; McDermott MF; Tooze R; Doffinger R; Savic S
J Clin Immunol; 2021 Feb; 41(2):441-457. PubMed ID: 33284430
[TBL] [Abstract][Full Text] [Related]
7. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
[TBL] [Abstract][Full Text] [Related]
8. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
[TBL] [Abstract][Full Text] [Related]
9. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
[TBL] [Abstract][Full Text] [Related]
10. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
11. Rosai-Dorfman disease involving the central nervous system: seven cases from one institute.
Tian Y; Wang J; Li M; Lin S; Wang G; Wu Z; Ge M; Pirotte BJ
Acta Neurochir (Wien); 2015 Sep; 157(9):1565-71. PubMed ID: 26210482
[TBL] [Abstract][Full Text] [Related]
12. Rosai-Dorfman Disease between Proliferation and Neoplasia.
Elbaz Younes I; Sokol L; Zhang L
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358690
[TBL] [Abstract][Full Text] [Related]
13. Recurrent central nervous system Rosai-Dorfman disease with KRAS mutation: a case report.
Wang Q; Ren H; Zheng L; Wang J; Zhong D
Diagn Pathol; 2023 Feb; 18(1):21. PubMed ID: 36782249
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
[TBL] [Abstract][Full Text] [Related]
15. Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of This Rare Disorder.
Cai Y; Shi Z; Bai Y
Acta Haematol; 2017; 138(1):14-23. PubMed ID: 28614806
[TBL] [Abstract][Full Text] [Related]
16. KRAS 117N positive Rosai-Dorfman disease with atypical features.
Jafri ZA; Reddy SP; Cassarino DS
J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal Rosai-Dorfman Disease with KRAS mutation case report and literature review.
Zhang W; Fang L; Wang J; Ma X; Hu X; Liu W
J Cardiothorac Surg; 2024 Apr; 19(1):166. PubMed ID: 38561747
[TBL] [Abstract][Full Text] [Related]
18. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutation leading to central nervous system rosai-dorfman disease.
Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
[TBL] [Abstract][Full Text] [Related]
20. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
